The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rus, V.
Right arrow Articles by Via, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rus, V.
Right arrow Articles by Via, C. S.

The Journal of Immunology, Vol 155, Issue 5 2396-2406, Copyright © 1995 by American Association of Immunologists

ARTICLES

Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells

V Rus, A Svetic, P Nguyen, WC Gause and CS Via
Research Service, Baltimore VA Medical Center, MD 21201, USA.

Acute and chronic graft-versus-host disease (GVHD) in the parent-into- F1 model are mediated by predominantly cellular or humoral immune responses, respectively, and are strikingly different entities by 2 wk of disease. Both forms of GVHD, however, evolve from a common starting point, i.e., donor CD4+ T cell recognition of host alloantigen and IL-2 production. Our study examines the first 2 wk of GVHD to delineate the events that critically influence GVHD development. Surprisingly, both forms of GVHD are initially characterized by increased Th2 cytokine (IL- 4 and IL-10) production and B cell activation which persists into wk 2. The earliest distinguishing features of acute GVHD were detectable at days 5 through 7 of disease and consisted of 1) expansion of donor CD8+ T cells, and 2) increased IFN-gamma production by donor CD4+ and CD8+ T cells. Interestingly, IFN-gamma production by donor CD4+ T cells was not seen if donor CD8+ T cells were not engrafted in comparable numbers. Chronic GVHD in the DBA-into-BDF1 model was found to be caused by a relative defect in the ability of DBA CD8+ T cells to induce acute GVHD and to produce IFN-gamma. These studies demonstrate that both acute and chronic GVHD begin as a Th2 cytokine-mediated, B cell stimulatory response. The transition to acute GVHD is critically dependent on the engraftment of donor CD8+ T cells, which terminate B cell hyperactivity by 1) eliminating activated B cells and 2) promoting IFN-gamma secretion by donor CD4+ T cells.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. Puliaev, I. Puliaeva, L. A. Welniak, A. E. Ryan, M. Haas, W. J. Murphy, and C. S. Via
CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus
J. Immunol., July 1, 2008; 181(1): 47 - 61.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Hurchla, J. R. Sedy, and K. M. Murphy
Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation
J. Immunol., May 15, 2007; 178(10): 6073 - 6082.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Rus, V. Nguyen, R. Puliaev, I. Puliaeva, V. Zernetkina, I. Luzina, J. C. Papadimitriou, and C. S. Via
T Cell TRAIL Promotes Murine Lupus by Sustaining Effector CD4 Th Cell Numbers and by Inhibiting CD8 CTL Activity
J. Immunol., March 15, 2007; 178(6): 3962 - 3972.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Grader-Beck, L. Casciola-Rosen, T. J. Lang, R. Puliaev, A. Rosen, and C. S. Via
Apoptotic Splenocytes Drive the Autoimmune Response to Poly(ADP-ribose) Polymerase 1 in a Murine Model of Lupus
J. Immunol., January 1, 2007; 178(1): 95 - 102.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kim, W. S. Choi, H. Kang, H. J. Kim, J.-H. Suh, S. Sakaguchi, and B. Kwon
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
J. Immunol., May 1, 2006; 176(9): 5223 - 5231.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. J. Lee
New approaches for preventing and treating chronic graft-versus-host disease
Blood, June 1, 2005; 105(11): 4200 - 4206.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
E Mozes, J Lovchik, H Zinger, and D S Singer
MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice
Lupus, April 1, 2005; 14(4): 308 - 314.
[Abstract] [PDF]

Home page
 BloodHome page
A.-M. Wagner, K. Beier, E. Christen, G. A. Hollander, and W. Krenger
Leydig cell injury as a consequence of an acute graft-versus-host reaction
Blood, April 1, 2005; 105(7): 2988 - 2990.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Kim, W. S. Choi, S. La, J.-H. Suh, B.-S. Kim, H. R. Cho, B. S. Kwon, and B. Kwon
Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells
Blood, March 1, 2005; 105(5): 2206 - 2213.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Sato, H. Thorlacius, B. Johnston, T. L. Staton, W. Xiang, D. R. Littman, and E. C. Butcher
Role for CXCR6 in Recruitment of Activated CD8+ Lymphocytes to Inflamed Liver
J. Immunol., January 1, 2005; 174(1): 277 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
T. Iwasaki
Recent Advances in the Treatment of Graft-Versus-Host Disease
Clin. Med. Res., November 1, 2004; 2(4): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. E. Anderson, J. M. McNiff, C. Matte, I. Athanasiadis, W. D. Shlomchik, and M. J. Shlomchik
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
Blood, September 1, 2004; 104(5): 1565 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Couriel, R. Saliba, K. Hicks, C. Ippoliti, M. de Lima, C. Hosing, I. Khouri, B. Andersson, J. Gajewski, M. Donato, et al.
Tumor necrosis factor-{alpha} blockade for the treatment of acute GVHD
Blood, August 1, 2004; 104(3): 649 - 654.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Wysocki, S. B. Burkett, A. Panoskaltsis-Mortari, S. L. Kirby, A. D. Luster, K. McKinnon, B. R. Blazar, and J. S. Serody
Differential Roles for CCR5 Expression on Donor T Cells during Graft-versus-Host Disease Based on Pretransplant Conditioning
J. Immunol., July 15, 2004; 173(2): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Puliaev, P. Nguyen, F. D. Finkelman, and C. S. Via
Differential Requirement for IFN-{gamma} in CTL Maturation in Acute Murine Graft-versus-Host Disease
J. Immunol., July 15, 2004; 173(2): 910 - 919.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Lang, P. Nguyen, J. C. Papadimitriou, and C. S. Via
Increased Severity of Murine Lupus in Female Mice Is Due to Enhanced Expansion of Pathogenic T Cells
J. Immunol., December 1, 2003; 171(11): 5795 - 5801.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Adams, N. Nagy, F. Paulart, M.-L. Vanderhaeghen, M. Goldman, and V. Flamand
CD8+ T Lymphocytes Regulating Th2 Pathology Escape Neonatal Tolerization
J. Immunol., November 15, 2003; 171(10): 5071 - 5076.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sasaki, H. Hasegawa, M. Kohno, A. Inoue, M. R. Ito, and S. Fujita
Antagonist of Secondary Lymphoid-Tissue Chemokine (CCR Ligand 21) Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
J. Immunol., January 1, 2003; 170(1): 588 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. M. Flanagan, C. D. Jennings, S. W. Goes, B. E. Caywood, R. Gross, A. M. Kaplan, and J. S. Bryson
Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease
J. Leukoc. Biol., October 1, 2002; 72(4): 762 - 768.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Rossi, B. R. Blazar, C. L. Farrell, D. M. Danilenko, D. L. Lacey, K. I. Weinberg, W. Krenger, and G. A. Hollander
Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease
Blood, June 28, 2002; 100(2): 682 - 691.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Lang, P. Nguyen, R. Peach, W. C. Gause, and C. S. Via
In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function
J. Immunol., April 15, 2002; 168(8): 3786 - 3792.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
D. G. Maloney, B. M. Sandmaier, S. Mackinnon, and J. A. Shizuru
Non-Myeloablative Transplantation
Hematology, January 1, 2002; 2002(1): 392 - 421.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
C. S. Via, A. Shustov, V. Rus, T. Lang, P. Nguyen, and F. D. Finkelman
In Vivo Neutralization of TNF-{alpha} Promotes Humoral Autoimmunity by Preventing the Induction of CTL
J. Immunol., December 15, 2001; 167(12): 6821 - 6826.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-h. Ogawa, G. Nagamatsu, M. Watanabe, S. Watanabe, T. Hayashi, S. Horita, K. Nitta, H. Nihei, K. Tezuka, and R. Abe
Opposing Effects of Anti-Activation-Inducible Lymphocyte- Immunomodulatory Molecule/Inducible Costimulator Antibody on the Development of Acute Versus Chronic Graft-Versus-Host Disease
J. Immunol., November 15, 2001; 167(10): 5741 - 5748.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Nozawa, J. Ohata, J. Sakurai, H. Hashimoto, H. Miyajima, H. Yagita, K. Okumura, and M. Azuma
Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases
J. Immunol., November 1, 2001; 167(9): 4981 - 4986.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. W. J. van Esser, B. van der Holt, E. Meijer, H. G. M. Niesters, R. Trenschel, S. F. T. Thijsen, A. M. van Loon, F. Frassoni, A. Bacigalupo, U. W. Schaefer, et al.
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT
Blood, August 15, 2001; 98(4): 972 - 978.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Snider and H. Liang
Early Intestinal Th1 Inflammation and Mucosal T Cell Recruitment During Acute Graft-Versus-Host Reaction
J. Immunol., May 15, 2001; 166(10): 5991 - 5999.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Lu, S. Sakamaki, H. Kuroda, T. Kusakabe, Y. Konuma, T. Akiyama, A. Fujimi, N. Takemoto, K. Nishiie, T. Matsunaga, et al.
Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603
Blood, February 15, 2001; 97(4): 1123 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. R. Tschetter, E. Mozes, and G. M. Shearer
Progression from Acute to Chronic Disease in a Murine Parent-into-F1 Model of Graft-Versus-Host Disease
J. Immunol., November 15, 2000; 165(10): 5987 - 5994.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Foucras, J. D. Coudert, C. Coureau, and J.-C. Guery
Dendritic Cells Prime In Vivo Alloreactive CD4 T Lymphocytes Toward Type 2 Cytokine- and TGF-{beta}-Producing Cells in the Absence of CD8 T Cell Activation
J. Immunol., November 1, 2000; 165(9): 4994 - 5003.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Miura, D. Mizuki, S. Sasaki, S. Hasegawa, H. Sashinami, and A. Nakane
Host Resistance to Listeria monocytogenes Infection Is Enhanced but Resistance to Staphylococcus aureus Infection Is Reduced in Acute Graft-versus-Host Disease in Mice
Infect. Immun., July 1, 2000; 68(7): 4340 - 4343.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Krenger, S. Rossi, L. Piali, and G. A. Hollander
Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells
Blood, July 1, 2000; 96(1): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto
IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
J. Immunol., June 1, 2000; 164(11): 6067 - 6074.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. M. Sloand, S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo
Blood, April 1, 2000; 95(7): 2269 - 2274.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Sakurai, J. Ohata, K. Saito, H. Miyajima, T. Hirano, T. Kohsaka, S. Enomoto, K. Okumura, and M. Azuma
Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells
J. Immunol., January 15, 2000; 164(2): 664 - 669.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. L. Stoll and J. Gavalchin
Systemic lupus erythematosus--messages from experimental models
Rheumatology, January 1, 2000; 39(1): 18 - 27.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
D. L. Flanagan, C. D. Jennings, and J. S. Bryson
Th1 Cytokines and NK Cells Participate in the Development of Murine Syngeneic Graft-Versus-Host Disease
J. Immunol., August 1, 1999; 163(3): 1170 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. DerSimonian, L. Pan, C. Yatko, A. Rodrigue-Way, E. Johnson, and A. S. B. Edge
Human Anti-Porcine T Cell Response: Blocking with Anti-Class I Antibody Leads to Hyporesponsiveness and a Switch in Cytokine Production
J. Immunol., June 15, 1999; 162(12): 6993 - 7001.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Pan, T. Teshima, G. R. Hill, D. Bungard, Y. S. Brinson, V. S. Reddy, K. R. Cooke, and J. L.M. Ferrara
Granulocyte Colony-Stimulating Factor-Mobilized Allogeneic Stem Cell Transplantation Maintains Graft-Versus-Leukemia Effects Through a Perforin-Dependent Pathway While Preventing Graft-Versus-Host Disease
Blood, June 15, 1999; 93(12): 4071 - 4078.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. E. Buhlmann, M. Gonzalez, B. Ginther, A. Panoskaltsis-Mortari, B. R. Blazar, D. L. Greiner, A. A. Rossini, R. Flavell, and R. J. Noelle
Cutting Edge: Sustained Expansion of CD8+ T Cells Requires CD154 Expression by Th Cells in Acute Graft Versus Host Disease
J. Immunol., April 15, 1999; 162(8): 4373 - 4376.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Okubo, E. Hagiwara, S. Ohno, T. Tsuji, A. Ihata, A. Ueda, A. Shirai, I. Aoki, K. Okuda, J.-i. Miyazaki, et al.
Administration of an IL-12-Encoding DNA Plasmid Prevents the Development of Chronic Graft-Versus-Host Disease (GVHD)
J. Immunol., April 1, 1999; 162(7): 4013 - 4017.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Chen, M. A. Maldonado, M. Madaio, and R. A. Eisenberg
The Role of Host (Endogenous) T Cells in Chronic Graft-Versus-Host Autoimmune Disease
J. Immunol., December 1, 1998; 161(11): 5880 - 5885.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Shustov, P. Nguyen, F. Finkelman, K. B. Elkon, and C. S. Via
Differential Expression of Fas and Fas Ligand in Acute and Chronic Graft-Versus-Host Disease: Up-Regulation of Fas and Fas Ligand Requires CD8+ T Cell Activation and IFN-{gamma} Production
J. Immunol., September 15, 1998; 161(6): 2848 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Ellison, J. M. M. Fischer, K. T. HayGlass, and J. G. Gartner
Murine Graft-Versus-Host Disease in an F1-Hybrid Model Using IFN-{gamma} Gene Knockout Donors
J. Immunol., July 15, 1998; 161(2): 631 - 640.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Mori, T. Nishimura, Y. Ikeda, T. Hotta, H. Yagita, and K. Ando
Involvement of Fas-Mediated Apoptosis in the Hematopoietic Progenitor Cells of Graft-Versus-Host Reaction-Associated Myelosuppression
Blood, July 1, 1998; 92(1): 101 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. Shankar, J. Scott Bryson, C. Darrell Jennings, P. E. Morris, and D. A. Cohen
Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation
Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 235 - 242.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.